Clinical Trial Update: Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF) [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial assessing three dosing regimens of NeoFuse with MasterGraft granules for posterolateral lumbar fusion in degenerative spine condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spinal Stenosis
• Spondylolisthesis

Drugs mentioned

• MasterGraft (MasterGraft granules)
• NeoFuse

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Degenerative Disc Disease, Spondylolisthesis | Phase 1, Phase 2 | Status: COMPLETED